Injective Coin (INJ) continues to make headlines due to its announcements, price predictions, and collaborations. The coin is predicted to reclaim its $50 position this year, while the Altaris upgrade has been launched on the Mainnet, stirring optimistic sentiments among investors. Concurrently, a decline prediction to $10 has been noted. Despite underperforming recently, it plans to launch a Layer-3 Chain on Arbitrum but also faces competition from emerging Layer 1 chains like Thorchain (RUNE). Meanwhile, bullish indicators suggest positive momentum for
Injective and
Cosmos. Likewise, Tria's Unchained has introduced chain abstraction into the Injective ecosystem. Furthermore,
Injective is showing strength against retracements, with predictions of hitting $50 this month. An integration with Binance Pay and Ondo Finance has expanded Injective's payment and stabilization capabilities. However, it has struggled against competitors Algotech and Ordi. While it integrates Mountain Protocol, enabling stablecoin USDM as collateral for derivatives, the coin is also pivoting focus to AI in collaboration with Raboo. Overall, Injective is showing potential for growth and facing competitions and challenges concurrently.
Injective Coin News Analytics from Wed, 06 Dec 2023 08:00:00 GMT to Tue, 06 Aug 2024 21:12:29 GMT -
Rating 5
- Innovation 3
- Information 8
- Rumor 2
